Highly Watched TG Therapeutics Smashes Profit Views — With A Caveat
BREAKING: Futures Rise; Palantir, Robinhood Earnings AheadTG Therapeutics (TGTX) stock jumped on Monday after the biotech company reported adjusted earnings of 161.7 million in third-quarter sales.On average, analysts polled by FactSet expected TG to report 22 cents earnings per share and 365 million, stemming from a deferred tax asset valuation allowance, Evercore ISI analyst Michael DiFiore said in ...